FARN vs. FUM, SCLP, POLB, 4BB, REDX, ETX, TRX, AVCT, AREC, and C4XD
Should you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Futura Medical (FUM), Scancell (SCLP), Poolbeg Pharma (POLB), 4basebio (4BB), Redx Pharma (REDX), e-therapeutics (ETX), Tissue Regenix Group (TRX), Avacta Group (AVCT), Arecor Therapeutics (AREC), and C4X Discovery (C4XD). These companies are all part of the "biotechnology" industry.
Faron Pharmaceuticals Oy (LON:FARN) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
Futura Medical has higher revenue and earnings than Faron Pharmaceuticals Oy. Futura Medical is trading at a lower price-to-earnings ratio than Faron Pharmaceuticals Oy, indicating that it is currently the more affordable of the two stocks.
Faron Pharmaceuticals Oy received 131 more outperform votes than Futura Medical when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
Faron Pharmaceuticals Oy has a beta of -0.14, indicating that its stock price is 114% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
13.2% of Faron Pharmaceuticals Oy shares are held by institutional investors. Comparatively, 36.0% of Futura Medical shares are held by institutional investors. 41.8% of Faron Pharmaceuticals Oy shares are held by insiders. Comparatively, 32.9% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Faron Pharmaceuticals Oy has a net margin of 0.00% compared to Futura Medical's net margin of -299.73%. Faron Pharmaceuticals Oy's return on equity of 0.00% beat Futura Medical's return on equity.
In the previous week, Futura Medical had 1 more articles in the media than Faron Pharmaceuticals Oy. MarketBeat recorded 3 mentions for Futura Medical and 2 mentions for Faron Pharmaceuticals Oy. Futura Medical's average media sentiment score of 0.25 beat Faron Pharmaceuticals Oy's score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.
Summary
Futura Medical beats Faron Pharmaceuticals Oy on 9 of the 15 factors compared between the two stocks.
Get Faron Pharmaceuticals Oy News Delivered to You Automatically
Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FARN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Faron Pharmaceuticals Oy Competitors List
Related Companies and Tools
